A new study published in JAMA suggests that noninvasive prenatal screening—a form of generic testing designed to detect chromosomal abnormalities in fetuses—can also detect cancer in pregnant women. #Cancer #Women @drhealthpress
The Harmony Test scrutinises the baby’s cell free DNA. Its predictive value is over 99.9% for Down’s syndrome, and slightly less for Edwards syndrome (98%) and Patau syndrome (80%). This is a significant accuracy improvement on earlier methods.